Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Open-Label, Non Randomized Phase 2 Study With Safety Run-In

NCT02249429

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Weill Cornell Medicine New York, United States
  • University Clinical Center Republic of Srpska Banja Luka, Bosnia and Herzegovina
  • University Clinical Center Sarajevo Sarajevo, Bosnia and Herzegovina
  • Insitute Curie Saint-Cloud, Paris, France
View Trial Details
Completed

S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

NCT00770224

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Saint Anthony's Hospital at Saint Anthony's Health Center Alton, Illinois, United States
  • Cancer Care Center of Decatur Decatur, Illinois, United States
View all 114 locations
View Trial Details
Completed

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

NCT00137995

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Australian leukemia and lymphoma group Sydney, Australia
  • Groupe d'atude des lymphome de l'adulte Yvoir, Belgium
  • Czech Lymphoma study group Prague, Czechia
View Trial Details
Completed

Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's Lymphoma

NCT00438802

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoblastic Lymphadenopathy, +14 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View Trial Details
Completed

Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma

NCT00004228

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 176 locations
View Trial Details

Related conditions